A Systematic Review of Clinical Practice Guidelines for the Diagnosis and Management of Bronchiolitis.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
07 10 2020
Historique:
pubmed: 22 9 2019
medline: 16 3 2021
entrez: 22 9 2019
Statut: ppublish

Résumé

Bronchiolitis is the leading cause of hospital admission for respiratory disease among infants aged <1 year. Clinical practice guidelines can benefit patients by reducing the performance of unnecessary tests, hospital admissions, and treatment with lack of a supportive evidence base. This review aimed to identify current clinical practice guidelines worldwide, appraise their methodological quality, and discuss variability across guidelines for the diagnosis and management of bronchiolitis. A systematic literature review of electronic databases EMBASE, Global Health, and Medline was performed. Manual searches of the gray literature, national pediatric society websites, and guideline-focused databases were performed, and select international experts were contacted to identify additional guidelines. The Appraisal of Guidelines for Research and Evaluation assessment tool was used by 2 independent reviewers to appraise each guideline. Thirty-two clinical practice guidelines met the selection criteria. Quality assessment revealed significant shortcomings in a number of guidelines, including lack of systematic processes in formulating guidelines, failure to state conflicts of interest, and lack of consultation with families of affected children. There was widespread agreement about a number of aspects, such as avoidance of the use of unnecessary diagnostic tests, risk factors for severe disease, indicators for hospital admission, discharge criteria, and nosocomial infection control. However, there was variability, even within areas of consensus, over specific recommendations, such as variable thresholds for oxygen therapy. Guidelines showed significant variability in recommendations for the pharmacological management of bronchiolitis, with conflicting recommendations over whether use of nebulized epinephrine, hypertonic saline, or bronchodilators should be routinely trialled. Future guidelines should aim to be compliant with international standards for clinical guidelines to improve their quality and clarity and to promote their adoption into practice. Variable recommendations between guidelines may reflect the evolving evidence base for bronchiolitis management, and platforms should be created to understand this variability and promote evidence-based recommendations.

Sections du résumé

BACKGROUND
Bronchiolitis is the leading cause of hospital admission for respiratory disease among infants aged <1 year. Clinical practice guidelines can benefit patients by reducing the performance of unnecessary tests, hospital admissions, and treatment with lack of a supportive evidence base. This review aimed to identify current clinical practice guidelines worldwide, appraise their methodological quality, and discuss variability across guidelines for the diagnosis and management of bronchiolitis.
METHODS
A systematic literature review of electronic databases EMBASE, Global Health, and Medline was performed. Manual searches of the gray literature, national pediatric society websites, and guideline-focused databases were performed, and select international experts were contacted to identify additional guidelines. The Appraisal of Guidelines for Research and Evaluation assessment tool was used by 2 independent reviewers to appraise each guideline.
RESULTS
Thirty-two clinical practice guidelines met the selection criteria. Quality assessment revealed significant shortcomings in a number of guidelines, including lack of systematic processes in formulating guidelines, failure to state conflicts of interest, and lack of consultation with families of affected children. There was widespread agreement about a number of aspects, such as avoidance of the use of unnecessary diagnostic tests, risk factors for severe disease, indicators for hospital admission, discharge criteria, and nosocomial infection control. However, there was variability, even within areas of consensus, over specific recommendations, such as variable thresholds for oxygen therapy. Guidelines showed significant variability in recommendations for the pharmacological management of bronchiolitis, with conflicting recommendations over whether use of nebulized epinephrine, hypertonic saline, or bronchodilators should be routinely trialled.
CONCLUSIONS
Future guidelines should aim to be compliant with international standards for clinical guidelines to improve their quality and clarity and to promote their adoption into practice. Variable recommendations between guidelines may reflect the evolving evidence base for bronchiolitis management, and platforms should be created to understand this variability and promote evidence-based recommendations.

Identifiants

pubmed: 31541233
pii: 5549996
doi: 10.1093/infdis/jiz240
doi:

Substances chimiques

Bronchodilator Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S672-S679

Investigateurs

Harry Campbell (H)
Harish Nair (H)
Rachel M Reeves (RM)
Anne Douglas (A)
Steve Cunningham (S)
Ricardo M Fernandes (RM)
Adam Meijer (A)
Thea Kølsen Fischer (TK)
Terho Heikkinen (T)
Carlo Giaquinto (C)
Charles Knirsch (C)
Sonia Stoszek (S)
Amanda Leach (A)
Clarisse Demont (C)
Scott Gallichan (S)
Jeroen Aerssens (J)
Philippe Beutels (P)
Louis Bont (L)
Andrew Pollard (A)
Peter Openshaw (P)
Judy Hackett (J)
Brian Rosen (B)
Eva Molero (E)

Commentaires et corrections

Type : ErratumIn
Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Amir Kirolos (A)

Usher Institute of Population Health Sciences and Informatics, Edinburgh.

Sara Manti (S)

Department of Pediatrics, University of Messina, Sicily, Italy.

Rachel Blacow (R)

Usher Institute of Population Health Sciences and Informatics, Edinburgh.

Gabriel Tse (G)

Usher Institute of Population Health Sciences and Informatics, Edinburgh.

Thomas Wilson (T)

Usher Institute of Population Health Sciences and Informatics, Edinburgh.

Martin Lister (M)

Royal Hospital for Sick Children, Edinburgh.

Steve Cunningham (S)

Department of Child Life and Health, Edinburgh.
Centre for Inflammation Research, University of Edinburgh, Edinburgh.

Alasdair Campbell (A)

Alder Hey Children's Hospital, Liverpool, United Kingdom.

Harish Nair (H)

Usher Institute of Population Health Sciences and Informatics, Edinburgh.

Rachel M Reeves (RM)

Usher Institute of Population Health Sciences and Informatics, Edinburgh.

Ricardo M Fernandes (RM)

Clinical Pharmacology and Therapeutics, Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon.

Harry Campbell (H)

Usher Institute of Population Health Sciences and Informatics, Edinburgh.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH